Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022

HIV testing was offered to 2,185 people receiving mpox (formerly monkeypox) vaccination, who reported not being HIV positive. Among them 390 were current PrEP users, and 131 had taken PrEP in the past. Of 958 individuals consenting testing, six were newly diagnosed with HIV. Two patients had symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Pittalis, Silvia, Mazzotta, Valentina, Orchi, Nicoletta, Abbate, Isabella, Gagliardini, Roberta, Gennaro, Elisabetta, Faticoni, Augusto, Piselli, Pierluca, Rozera, Gabriella, Cicalini, Stefania, Maggi, Fabrizio, Girardi, Enrico, Vaia, Francesco, Antinori, Andrea, Puro, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716645/
https://www.ncbi.nlm.nih.gov/pubmed/36695459
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.48.2200890
Descripción
Sumario:HIV testing was offered to 2,185 people receiving mpox (formerly monkeypox) vaccination, who reported not being HIV positive. Among them 390 were current PrEP users, and 131 had taken PrEP in the past. Of 958 individuals consenting testing, six were newly diagnosed with HIV. Two patients had symptomatic primary HIV infection. None of the six patients had ever taken PrEP. Mpox vaccination represents an important opportunity for HIV testing and counselling about risk reduction and PrEP.

Ejemplares similares